Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from China Pacific Insurance (Group) Co ( (HK:2601) ).
China Pacific Insurance (Group) Co., Ltd. has announced the current composition of its board of directors, naming Fu Fan as executive director and chairman and Zhao Yonggang as executive director and president, alongside a mix of non-executive and independent non-executive directors. The group also detailed the membership and leadership of its five key board committees—covering audit and related party transactions, strategy and ESG, nomination and remuneration, risk compliance, and technological innovation and consumer rights protection—clarifying governance roles and oversight responsibilities for investors and other stakeholders.
The announcement underscores the company’s emphasis on structured corporate governance and specialized committee oversight as it navigates strategic, risk, and ESG-related priorities. By specifying committee chairs and members, China Pacific Insurance seeks to enhance transparency around decision-making processes, which may bolster investor confidence and support regulatory compliance in both mainland China and Hong Kong.
The most recent analyst rating on (HK:2601) stock is a Buy with a HK$46.00 price target. To see the full list of analyst forecasts on China Pacific Insurance (Group) Co stock, see the HK:2601 Stock Forecast page.
More about China Pacific Insurance (Group) Co
China Pacific Insurance (Group) Co., Ltd. is a major Chinese insurance group operating in life, property and casualty, and other insurance-related financial services. Listed in Hong Kong under stock code 02601, the company focuses on the domestic Chinese market while also serving international investors through its H-share listing.
Average Trading Volume: 15,926,591
Technical Sentiment Signal: Buy
Current Market Cap: HK$432.4B
See more insights into 2601 stock on TipRanks’ Stock Analysis page.

